OraPharma

Novel topical formulations for treatment of dental diseases

Orapharma is a specialty pharmaceuticals company focusing on developing and commercializing novel therapeutics to improve and maintain oral health. The company developed ARESTIN, an oral topical formulation of minocycline, that was approved by the FDA in 2001 for treatment of periodontal disease. Orapharma completed its IPO in 2000 and was acquired by J&J in 2002.

Status

Acquired by Johnson & Johnson in 2002

Year of Investment

1997

Strategy

Life Sciences

Subsector

Specialty Pharmaceuticals

Location

Horsham, Pennsylvania

Website